Review



ds2 drug  (Tocris)


Bioz Verified Symbol Tocris is a verified supplier
Bioz Manufacturer Symbol Tocris manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 92
      Buy from Supplier

    Structured Review

    Tocris ds2 drug
    FIGURE 9 Treatment with positive allosteric modulator <t>(DS2)</t> of δ-GABAA receptors (δ-GABAARs) reduced anxiety in App mouse models of Alzheimer's disease (AD). (a) Schematic of DS2 drug injection and light–dark chamber test. (b) Dose response curve of DS2 drug in WT and AppNL-
    Ds2 Drug, supplied by Tocris, used in various techniques. Bioz Stars score: 92/100, based on 47 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ds2 drug/product/Tocris
    Average 92 stars, based on 47 article reviews
    ds2 drug - by Bioz Stars, 2026-05
    92/100 stars

    Images

    1) Product Images from "Decreased extrasynaptic δ-GABA A receptors in PNN-associated parvalbumin interneurons correlates with anxiety in APP and tau mouse models of Alzheimer's disease."

    Article Title: Decreased extrasynaptic δ-GABA A receptors in PNN-associated parvalbumin interneurons correlates with anxiety in APP and tau mouse models of Alzheimer's disease.

    Journal: British journal of pharmacology

    doi: 10.1111/bph.16441

    FIGURE 9 Treatment with positive allosteric modulator (DS2) of δ-GABAA receptors (δ-GABAARs) reduced anxiety in App mouse models of Alzheimer's disease (AD). (a) Schematic of DS2 drug injection and light–dark chamber test. (b) Dose response curve of DS2 drug in WT and AppNL-
    Figure Legend Snippet: FIGURE 9 Treatment with positive allosteric modulator (DS2) of δ-GABAA receptors (δ-GABAARs) reduced anxiety in App mouse models of Alzheimer's disease (AD). (a) Schematic of DS2 drug injection and light–dark chamber test. (b) Dose response curve of DS2 drug in WT and AppNL-

    Techniques Used: Injection



    Similar Products

    ds2 drug  (Tocris)
    92
    Tocris ds2 drug
    FIGURE 9 Treatment with positive allosteric modulator <t>(DS2)</t> of δ-GABAA receptors (δ-GABAARs) reduced anxiety in App mouse models of Alzheimer's disease (AD). (a) Schematic of DS2 drug injection and light–dark chamber test. (b) Dose response curve of DS2 drug in WT and AppNL-
    Ds2 Drug, supplied by Tocris, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ds2 drug/product/Tocris
    Average 92 stars, based on 1 article reviews
    ds2 drug - by Bioz Stars, 2026-05
    92/100 stars
    		  Buy from Supplier
    drug substance ds2  (Pierre Fabre Group)
    90
    Pierre Fabre Group drug substance ds2
    FIGURE 9 Treatment with positive allosteric modulator <t>(DS2)</t> of δ-GABAA receptors (δ-GABAARs) reduced anxiety in App mouse models of Alzheimer's disease (AD). (a) Schematic of DS2 drug injection and light–dark chamber test. (b) Dose response curve of DS2 drug in WT and AppNL-
    Drug Substance Ds2, supplied by Pierre Fabre Group, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/drug substance ds2/product/Pierre Fabre Group
    Average 90 stars, based on 1 article reviews
    drug substance ds2 - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    FIGURE 9 Treatment with positive allosteric modulator (DS2) of δ-GABAA receptors (δ-GABAARs) reduced anxiety in App mouse models of Alzheimer's disease (AD). (a) Schematic of DS2 drug injection and light–dark chamber test. (b) Dose response curve of DS2 drug in WT and AppNL-

    Journal: British journal of pharmacology

    Article Title: Decreased extrasynaptic δ-GABA A receptors in PNN-associated parvalbumin interneurons correlates with anxiety in APP and tau mouse models of Alzheimer's disease.

    doi: 10.1111/bph.16441

    Figure Lengend Snippet: FIGURE 9 Treatment with positive allosteric modulator (DS2) of δ-GABAA receptors (δ-GABAARs) reduced anxiety in App mouse models of Alzheimer's disease (AD). (a) Schematic of DS2 drug injection and light–dark chamber test. (b) Dose response curve of DS2 drug in WT and AppNL-

    Article Snippet: Therefore, in in vivo dosing experiments, mice were treated with the DS2 drug (Tocris UK), dissolved in DMSO (ThermoFisher Scientific, Cambridge, UK), 1, 2 and 4 mg kg 1, intraperitoneal injection (ip) or vehicle.

    Techniques: Injection